We create value
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
Board of directors
Board of Directors
Jan Gustavsson

Chairman of the Board

Born 1946. Board member and chairman since 2017.
Education: Bachelor’s degree in Finance, Lund University.
Other ongoing assignments: Chairman of the board in Interlite AB and Incendia Pharma AB. Owner of JGB Consulting.
Previous assignments in the last five years: Chairman of the Board of Eliq AB, Chairman of the Board of Sotenäs RehabCenter AB. Board member of Ikano Bostad Stockholm Holding AB
Holdings: 28,572 shares.

Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners.

Christian Månsson

Member of the Board

Born 1980. Board member since 2023.
Education: M. Sc. chemical engineering, Lund University of Technology, and a bachelor’s degree in business administration, Lund University School of Economics and Management.
Other ongoing assignments: CEO and board member of Life Science Partner Skåne AB, Board member of Carbiotix, and board member of Öresund Growth Partner.
Previous assignments in the last five years: None.
Holdings: 134,398 A shares and 32,217 via related parties.

Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners.

Joern Berthelsen

Member of the Board

Born 1949. Board member since 2017.
Education: BSc in Biology, Bachelor of Commerce, University of Copenhagen.
Other ongoing assignments: Board deputy in Seawood AB.
Previous assignments in the last five years: Board member and COO of Bertram Pharma ApS until 2017.
Holdings: 26,988 A shares and 1,640 A shares through related parties.

Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners

Torsten Helsing

Member of the Board

Born 1957. Board member since 2007 and CEO since 2016.
Other ongoing assignments: CEO of aXimed AB, aXimed AS and Driftkultur AS. Chairman of Guizhou aXimed Health Food Co., Ltd, Soya AS and aXichem AS. Board member of aXimed HK Ltd, Manakin Ltd, Tofu AS and Incendia Pharma AB.
Previous assignments in the last five years: None.
Holdings: 1,983,320 A shares through Manakin Ltd.

Dependency: Dependency in relation to the company and its management, dependence in relation to the company's major owners.

Gunilla Savring

Director Investor Relations

Born 1962. Board member since 2014.

Education: Executive MBA, Lund University.

Other ongoing assignments: Board member of Aqilion AB, board member of Incendia AB, managing director and board member of Savring Consulting AB.

Previous assignments in the last five years: Board member of Clinical Laserthermia Systems AB.

Holdings: 19,757 A shares through Savring Consulting AB.

Dependency: Dependent in relation to the company and its management, independent in relation to the company's major owners.

Edward van den Elsen

Member of the Board

Born: 1968. Board member since 2022.

Education: Bachelor of Science, University of Wageningen.

Other assignments: No other assignments.

Holdings: No shares in aXichem

Dependency: Independent in relation to the company and its management, independent in relation to the company's major owners.